申请人:Dana-Farber Cancer Institute, Inc.
公开号:US11530209B2
公开(公告)日:2022-12-20
Provided herein are compounds that interrupt the function of SALL4. Also described are pharmaceutical compositions and medical uses of these compounds.
本文提供了能干扰 SALL4 功能的化合物。还描述了这些化合物的药物组合物和医疗用途。